The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab to treat adults with bullous pemphigoid.

Trump decided to keep the government's free COVID test program running, just minutes before COVIDtests.gov was set to shut down.

A study has found that patients with ischemic stroke and COVID-19, compared with patients without COVID-19, experience worse recovery outcomes.

Orismilast may be an effective and safe novel treatment option for adult patients with moderate to severe atopic dermatitis.

A systematic review confirmed the safety and efficacy of a pulsed dye laser for the treatment of port-wine birthmarks and infantile hemangiomas.

Formulation characteristics can explain the observed variation in benzene levels of over-the-counter benzoyl peroxide-containing products.

Those with a history of depression have more physical health conditions and develop additional physical conditions at a faster rate.

Federal funding for medical research has dropped by $1 billion this year, raising alarm among universities, medical centers, and lawmakers.

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Mohs surgery complications risk is increased in patients who have smoked tobacco when compared with those who have never used any form of nicotine.

HealthDay News — New numbers have been released by the Texas Department of State Health Services (DSHS) in an update on the measles outbreak in Gaines County: 22 children and two adults have been ...

Commercials run by Hims & Hers advertise prescription injectable weight-loss drugs without disclosing safety and risk information.